Selected article for: "blood glucose and HDL cholesterol"

Author: Rao, Xiaoquan; Zhao, Shi; Braunstein, Zachary; Mao, Hong; Razavi, Michael; Duan, Lihua; Wei, Yingying; Toomey, Amelia C.; Rajagopalan, Sanjay; Zhong, Jixin
Title: Oxidized LDL upregulates macrophage DPP4 expression via TLR4/TRIF/CD36 pathways
  • Document date: 2019_2_7
  • ID: 1n7xjjd5_26
    Snippet: Monocytes and macrophages are central effectors of innate immunity and are now recognized as key pathophysiologic players in the development of various chronic conditions such as atherosclerosis [16, 17] . Our recent study indicates that DPP4 expression on circulating monocytes was increased in atherosclerosis and was associated with atherosclerotic burden [14] . Since DPP4 up-regulation has been associated with obesity [8, 9, 11] , we divided pa.....
    Document: Monocytes and macrophages are central effectors of innate immunity and are now recognized as key pathophysiologic players in the development of various chronic conditions such as atherosclerosis [16, 17] . Our recent study indicates that DPP4 expression on circulating monocytes was increased in atherosclerosis and was associated with atherosclerotic burden [14] . Since DPP4 up-regulation has been associated with obesity [8, 9, 11] , we divided patients into two groups: obese (BMI ≥ 30) and non-obese (BMI b 30). The biological characteristics and markers are shown in Table 1 . There were no significant differences in age, SBP, DBP, HR, and biochemical parameters such as aspartate transaminase (AST), alanine transaminase (ALT), creatinine, creatine kinase, alkaline phosphatase, albumin, sodium, potassium, chloride, HDL\ \C, blood urea nitrogen, and total protein. The levels of HOMA-IR, non-HDL cholesterol, uric acid, triglycerides, fasting blood glucose, fasting insulin, and leptin were significantly increased, while adiponectin levels were lower in obese patients with atherosclerosis (Table 1) .

    Search related documents:
    Co phrase search for related documents
    • aspartate transaminase and blood glucose: 1, 2, 3
    • aspartate transaminase and blood urea: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15
    • aspartate transaminase and blood urea nitrogen: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
    • aspartate transaminase and creatine kinase: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
    • aspartate transaminase and innate immunity: 1
    • AST aspartate transaminase and blood glucose: 1, 2
    • AST aspartate transaminase and blood urea: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • AST aspartate transaminase and blood urea nitrogen: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • AST aspartate transaminase and creatine kinase: 1, 2, 3, 4, 5, 6, 7
    • AST aspartate transaminase and innate immunity: 1
    • atherosclerotic burden and blood glucose: 1
    • biochemical parameter and creatine kinase: 1
    • biological characteristic and marker biological characteristic: 1
    • blood glucose and chronic condition: 1, 2, 3, 4, 5
    • blood glucose and creatine kinase: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • blood glucose and innate immunity: 1, 2, 3
    • blood glucose and insulin fast: 1, 2, 3
    • blood urea and creatine kinase: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21
    • blood urea and innate immunity: 1